Nyhet —
Setterwalls Life Sciences Report May 2024
Setterwalls har idag publicerat Life Sciences Report May 2024 som samlar nyheter och artiklar författade av våra specialister inom juridik avseende life sciences-området. Vi hoppas ni finner innehållet intressant och ger här en översikt över innehållet samt länkning till hela rapporten. God läsning och välkommen att kontakta oss!
- New regulation introduces stricter accessibility requirements – do your products and services meet the new requirements?
- Overview of recent developments regarding the distinction between marketing and non-commercial information in relation to medicinal products.
- The new Product Liability Directive and AI Liability Directive – implications for medical devices with AI functionalities.
- Key takeaways for the environmental risk assessment (ERA) in the proposal for new EU pharmaceutical legislation.
- EMA’s new recommendations to strengthen supply chains of critical medicines – a short recap of what and why
Recent developments and an update on Geographical Indications (GIs). - Switch and substitution of biological medicinal products in pharmacies.
- The Swedish Supreme Administrative Court seeks guidance from the CJEU on the interpretation of the provisions of EU law on the labelling of food for special medical purposes.
- Labelling sausages “riktig korv” (eng. real sausage) was misleading.
